Kopin Corporation (KOPN)
NASDAQ: KOPN
· Real-Time Price · USD
2.28
-0.06 (-2.56%)
At close: Sep 26, 2025, 3:59 PM
2.30
0.88%
After-hours: Sep 26, 2025, 07:57 PM EDT
Kopin Revenue Breakdown
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Defense Revenue | 6.22M | 8.46M | 12.14M | 10.43M | 10.44M | 8.23M | 7.08M | 5.85M | 7.09M | 4.76M | 5.92M | 3.48M | 3.78M | 4.99M | 4.77M | 1.4M | 2.18M | 1.79M | 1.5M | 1.54M | 49K |
| Defense Revenue Growth | -26.46% | -30.32% | +16.38% | -0.05% | +26.79% | +16.20% | +21.09% | -17.44% | +48.98% | -19.69% | +70.05% | -7.83% | -24.31% | +4.70% | +241.62% | -36.05% | +21.75% | +19.77% | -2.73% | +3040.82% | n/a |
| Industrial Revenue | 1.03M | 392K | 328K | 489K | 615K | 768K | 1.25M | 1.73M | 1.63M | 1.53M | 2.32M | 2.72M | 2.63M | 2.04M | 1.65M | 1.77M | n/a | n/a | n/a | n/a | n/a |
| Industrial Revenue Growth | +163.01% | +19.51% | -32.92% | -20.49% | -19.92% | -38.36% | -27.85% | +5.76% | +6.73% | -33.94% | -14.98% | +3.61% | +28.81% | +23.70% | -6.88% | n/a | n/a | n/a | n/a | n/a | n/a |
| License and Royalties Revenue | 49K | 72K | 94K | 129K | 112K | 107K | n/a | n/a | 2.81M | 4.91M | 4.3M | 4.1M | 2.7M | 3.56M | 2.56M | n/a | n/a | n/a | n/a | n/a | n/a |
| License and Royalties Revenue Growth | -31.94% | -23.40% | -27.13% | +15.18% | +4.67% | n/a | n/a | n/a | -42.83% | +14.01% | +5.03% | +51.59% | -24.07% | +38.94% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Medical Revenue | 213K | 359K | 1.66M | 2.27M | 1.17M | 900K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Medical Revenue Growth | -40.67% | -78.35% | -26.90% | +93.85% | +30.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | 908K | 1.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -26.60% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 8.21M | 10.06M | 14.21M | 12.61M | 11.56M | 9.19M | 29.24M | 9.36M | 1.56M | 2.14M | 10.17M | 7.67M | 6.45M | 8.18M | 11.5M | 7.83M | 6.94M | 6.87M | 2.21M |
| Americas Revenue Growth | -18.44% | -29.16% | +12.64% | +9.14% | +25.75% | -68.57% | +212.30% | +498.72% | -27.05% | -78.91% | +32.65% | +18.87% | -21.17% | -28.88% | +46.93% | +12.83% | +1.05% | +210.54% | n/a |
| Asia Pacific Revenue | 118K | 258K | 358K | 382K | 578K | 671K | 2.04M | 2.04M | 308K | 137K | 2.69M | 2.77M | 3.11M | 3.27M | 2.02M | 1.48M | 1.64M | 664K | 480K |
| Asia Pacific Revenue Growth | -54.26% | -27.93% | -6.28% | -33.91% | -13.86% | -67.17% | +0.25% | +562.01% | +124.82% | -94.91% | -2.78% | -10.93% | -5.01% | +62.53% | +36.61% | -10.17% | +147.29% | +38.33% | n/a |
| Europe Revenue | 130K | 217K | 82K | 326K | 202K | 172K | 231K | 326K | 10.04M | 9.3M | 335K | 451K | 346K | 221K | 405K | 210K | 235K | 348K | 306K |
| Europe Revenue Growth | -40.09% | +164.63% | -74.85% | +61.39% | +17.44% | -25.54% | -29.14% | -96.75% | +7.96% | +2675.22% | -25.72% | +30.35% | +56.56% | -45.43% | +92.86% | -10.64% | -32.47% | +13.73% | n/a |
| Other Americas Revenue | 23K | 11K | n/a | 12.61M | 11.56M | 5K | n/a | 4K | n/a | n/a | 10.17M | 7.67M | 6.45M | 8.18M | 1K | n/a | n/a | 101K | 2.21M |
| Other Americas Revenue Growth | +109.09% | n/a | -100.00% | +9.14% | +231020.00% | n/a | -100.00% | n/a | n/a | n/a | +32.65% | +18.87% | -21.17% | +817900.00% | n/a | n/a | n/a | -95.43% | n/a |
| United States Revenue | 8.18M | 10.05M | 14.21M | n/a | n/a | 9.19M | 9.91M | 9.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -18.58% | -29.24% | n/a | n/a | n/a | -7.32% | +5.88% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Sep 24, 2016 | Jun 25, 2016 | Mar 26, 2016 | Dec 26, 2015 | Sep 26, 2015 | Jun 27, 2015 | Mar 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.9M | 4.7M | 3.14M | 5.21M | 7.27M | 7.23M | 5.93M | 4.8M | 6.47M | 4.65M | 4.85M | 4.32M | 4.33M | 4.46M | 4.12M | 4.04M | 4.04M | 5.91M | 2.4M | 3.08M | 2.91M | 3.43M | 4.53M | 5.13M | 5.38M | 6.28M | 6.2M | 7.17M | 6.91M | 6.93M | 4.35M | 5.34M | 5.2M | 5.64M | 4.94M | 3.96M | 4.28M | 3.76M | 4.08M | 4.56M | 5.11M | 4.39M |
| Selling, General, and Administrative Revenue Growth | +4.22% | +49.81% | -39.73% | -28.36% | +0.50% | +21.97% | +23.56% | -25.79% | +39.11% | -4.22% | +12.33% | -0.17% | -3.07% | +8.42% | +2.03% | -0.12% | -31.58% | +145.90% | -22.01% | +5.85% | -15.23% | -24.20% | -11.74% | -4.57% | -14.44% | +1.34% | -13.48% | +3.65% | -0.26% | +59.19% | -18.54% | +2.78% | -7.82% | +14.25% | +24.66% | -7.50% | +13.86% | -7.86% | -10.47% | -10.76% | +16.46% | n/a |
| Research and Development Revenue | 907.91M | 1.24B | 3.1M | 2.6M | 1.84M | 2.1M | 2.24M | 3.09M | 3.13M | 2.31M | -5.61M | 3.44M | 5.15M | 5.41M | 5.23M | 3.75M | 3.89M | 3.56M | 4.39M | 2.72M | 2.22M | 2.34M | 2.66M | 2.39M | 3.33M | 4.97M | 3.87M | 4.6M | 4.53M | 4.45M | 4.67M | 5.25M | 4.68M | 4.28M | 3.76M | 4.12M | 4.12M | 4.04M | 3.88M | 4.01M | 4.88M | 4.86M |
| Research and Development Revenue Growth | -26.58% | +39817.09% | +19.31% | +41.15% | -12.43% | -6.33% | -27.42% | -1.35% | +35.47% | -141.23% | -262.94% | -33.12% | -4.87% | +3.36% | +39.48% | -3.46% | +9.06% | -18.89% | +61.76% | +22.27% | -5.07% | -12.13% | +11.43% | -28.25% | -32.95% | +28.40% | -15.89% | +1.62% | +1.67% | -4.59% | -11.19% | +12.30% | +9.26% | +13.97% | -8.88% | +0.09% | +1.97% | +4.15% | -3.23% | -17.93% | +0.49% | n/a |